ASBPW

Aspire Biopharma Holdings, Inc. Warrant
ASBPW

0.0615 USD
At close May 20, 4:00 PM EDT
1 day
0.00%
5 days
11.62%
1 month
-31.51%
3 months
-16.33%
6 months
190.09%
Year to date
29.47%
1 year
47.13%
5 years
-82.43%
10 years
-82.43%
 

About: Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.

0
Funds holding %
of 7,202 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

1% more capital invested

Capital invested by funds: $625K [Q4 2024] → $630K (+$5.21K) [Q1 2025]

0% more funds holding

Funds holding: 26 [Q4 2024] → 26 (+0) [Q1 2025]

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Research analyst outlook

We haven’t received any recent analyst ratings for ASBPW.

Financial journalist opinion

We haven’t received any recent news articles for ASBPW.

Charts implemented using Lightweight Charts™